$26.20 0.6%
HIMS Stock Price vs. AI Score
Data gathered: December 21

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - hims (HIMS)

Analysis generated December 5, 2024. Powered by Chat GPT.

Hims, also known as Hims & Hers Health Inc., is a telehealth company focused on providing affordable and accessible care to consumers. The company offers a wide range of telehealth services including dermatology, mental health, and primary care, which are delivered through their online platform. Hims targets Millennials and Gen Z consumers, aiming to destigmatize health-related conversations and simplify healthcare access.

Read full AI stock Analysis

Stock Alerts - hims (HIMS)

company logo hims | December 20
Reddit mentions are up by 230% in the last 24h.
company logo hims | December 19
Price is down by -6.3% in the last 24h.
company logo hims | December 18
Price is down by -5.5% in the last 24h.
company logo hims | December 18
Insider Alert: Dudum Andrew is selling shares

About hims

Hims & Hers Health, Inc. is a telemedicine company that operates Hims and Hers, which sell men's and women's personal care products. Hims, Inc. was founded in 2017 with the launch of Hims, and Hers was launched in 2018. In January 2019, Hims became the second-fastest startup to become a so-called 'unicorn' after Bird.


hims
Price $26.20
Target Price Sign up
Volume 15,270,000
Market Cap $5.76B
Year Range $11.26 - $34.23
Dividend Yield 0%
PE Ratio 59.91
Analyst Rating 38% buy
Industry Retail

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '24402M84M318M76M23M0.320
Q2 '24316M59M257M13M12M0.060
Q1 '24278M49M229M11M11M0.050
Q4 '23247M43M204M1.2M300,0000.010
Q3 '23227M39M187M-7.6M-7.8M-0.040

Insider Transactions View All

Dudum Andrew filed to sell 30,710 shares at $32.6.
December 17 '24
Dudum Andrew filed to sell 41,249 shares at $32.
December 17 '24
Becklund Irene filed to sell 7,319 shares at $32.2.
December 17 '24
Chi Michael filed to sell 193,601 shares at $32.2.
December 17 '24
Dudum Andrew filed to sell 30,710 shares at $32.6.
December 17 '24

What is the Market Cap of hims?

The Market Cap of hims is $5.76B.

What is hims' PE Ratio?

As of today, hims' PE (Price to Earnings) ratio is 59.91.

What is the current stock price of hims?

Currently, the price of one share of hims stock is $26.20.

How can I analyze the HIMS stock price chart for investment decisions?

The HIMS stock price chart above provides a comprehensive visual representation of hims' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling hims shares. Our platform offers an up-to-date HIMS stock price chart, along with technical data analysis and alternative data insights.

Does HIMS offer dividends to its shareholders?

As of our latest update, hims (HIMS) does not offer dividends to its shareholders. Investors interested in hims should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of hims?

Some of the similar stocks of hims are Costco, Dollar Tree, Target, Big Lots, and Macy's.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.